[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fHdmS2Q-5NWpIc20B7s_SneSlmOd6oj1SRAQg5mZcKKc":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":9,"nonDrugCount":6,"topConditions":11,"upcomingReadouts":34,"phaseBuckets":35,"rows":42},"Masimo Corporation",[4],103,false,3,0,10910,[12,15,18,21,24,27,29,31],{"name":13,"count":14},"Healthy",65,{"name":16,"count":17},"Surgery",9,{"name":19,"count":20},"Anemia",8,{"name":22,"count":23},"Anesthesia",5,{"name":25,"count":26},"Atrial Fibrillation",2,{"name":28,"count":26},"Evaluation of SpO2 Performance",{"name":30,"count":26},"Fever",{"name":32,"count":33},"Hypoxemia",1,[],[36,37,38,39,40,41],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[]]